Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
The global Vaccine Marketwas valued at USD 32.1 billion in 2016 and is projected to reach USD 59.01 billion by 2025, growing at a CAGR of 7% from 2017 to 2025.
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism. The vaccine production market is seeing a rise because of prevalence of infections and flu diseases.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing Cases of infections
1.2 Growing demand of immunization campaigns and programs
1.3 Growing focus on vaccine development and implementation
1.4 More funds for vaccine R&D in industries
2. Market Restraints
2.1 Product failure
2.2 High Cost of Vaccine development
Market Segmentation:
1. Global Vaccine Market, by Type:
1.1 Monovalent
1.2 Multivalent
2. Global Vaccine Market, by Technology:
2.1 Conjugate Vaccines
2.2 Inactivated and Subunit Vaccines
2.3 Live Attenuated Vaccines
2.4 Recombinant Vaccines
2.5 Toxoid Vaccines
3. Global Vaccine Market, by path ofAdministration:
3.1 Intramuscular and Subcutaneous Administration
3.2 Oral Administration
3.3 Other Routes of Administration
4. Global Vaccine Market, by Disease Indication:
4.1 Pneumococcal Disease
4.2 DTP
4.3 Influenza
4.4 Human Papilloma Virus
4.5 Meningococcal Disease
4.6 Polio
4.7 Rotavirus
4.8 Hepatitis
4.9 MMR
4.10 Varicella
4.11 Dengue
4.12 Other Disease Indications
5. Global Vaccine Market, by path ofEnd user:
5.1 Pediatrics
5.2 Adults
5.3 Veterinary Practices (Animals)
6. Global Vaccine Market, by Region:
6.1 North America (U.S., Canada, Mexico)
6.2 Europe (Germany, UK, France, Rest of Europe)
6.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
6.4 Latin America (Brazil, Argentina, Rest of Latin America)
6.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Pfizer, Inc.
2. Glaxosmithkline PLC.
3. Merck & Co., Inc.
4. Sanofi Pasteur SA
5. CSL Limited
6. Emergent Biosolutions, Inc.
7. Johnson & Johnson
8. Medimmune, LLC (A Subsidiary of Astrazeneca)
9. AstellasPharma, Inc.
10. Serum Institute of India
11. Bavarian Nordic
12. Mitsubishi Tanabe Pharma Corporation
13. Daiichi Sankyo Company, Limited
14. Protein Sciences Corporation
15. Panacea Biotec
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Vaccine Marketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
Request Sample 
Request Discount 
Inquire Before Buy
